Institute Of Urology And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 05-07-2024
- Paid Up Capital ₹ 0.14 M
as on 05-07-2024
- Company Age 29 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -10.47%
(FY 2020)
- Profit -12770.86%
(FY 2020)
- Ebitda -416.21%
(FY 2020)
- Net Worth -12.38%
(FY 2020)
- Total Assets 3.69%
(FY 2020)
About Institute Of Urology And Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.14 M, as per Ministry of Corporate Affairs (MCA) records.
Narendra Mohta, Dinesh Rathi, Suhas Salpekar, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85195MH1995PTC091077
- Company No.
091077
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jul 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Institute Of Urology And Research Centre?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Mohta  | Director | 27-Jul-1995 | Current |
| Dinesh Rathi | Director | 27-Jul-1995 | Current |
| Suhas Salpekar | Director | 27-Jul-1995 | Current |
| Purushottam Paldiwal | Director | 27-Jul-1995 | Current |
| Pradeep Katakwar | Director | 27-Jul-1995 | Current |
| Sanjay Kolte | Director | 31-Mar-1998 | Current |
Financial Performance of Institute Of Urology And Research Centre.
Institute Of Urology And Research Centre Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 10.47% decrease. The company also saw a substantial fall in profitability, with a 12770.86% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Institute Of Urology And Research Centre?
In 2018, Institute Of Urology And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Institute Of Urology And Research Centre?
Unlock and access historical data on people associated with Institute Of Urology And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Institute Of Urology And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Institute Of Urology And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
